FDA Label for Sleep Aid 25mg

View Indications, Usage & Precautions

Sleep Aid 25mg Product Label

The following document was submitted to the FDA by the labeler of this product Yyba Corp. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Active Ingredient (In Each Tablet)



Doxylamine Succinate 25 mg


Purpose



Night sleep-aid


Uses



Helps to reduce difficulty in falling asleep


Warnings



Ask a doctor before use if you have.

  • a breathing problem such as asthma, emphysema or chronic bronchitis
  • difficulty in urination due to enlargement of the prostate glad
  • glucoma
  • Ask a doctor or pharmacist before use if you are taking any other drugs.

    When usinf this product

    • avoid alcohol beverages
    • take only at bedtime
    • Stop use and ask a doctor if sleeplessness persists continuosly for more than two weeks. Insomnia may be s symptom of serious underlying medical illness.

      If pregnant of breast-feeding, as a health professional before use.


Otc - Keep Out Of Reach Of Children



Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away [1-800-222-1222]


Directions



  • adults and children 12 years and older:
  • take one tablet 30 minutes before going to bed; take one daily or as directed by a doctor

    • children under 12 years:
    • do not use


Other Information



  • store between 20° and 25°C (68° and 77°F)
  • protect from excessive moisture

Inactive Ingredients



dicalcium phosphate dihydrate, FD&C blue #1 aluminum lake, magnesium stearate, microcrystalline cellulose, sodium starch glycolate


Questions?



call toll-free 1-866-933-6337


Package Label.Principal Display Panel




* Please review the disclaimer below.